These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

740 related items for PubMed ID: 1663587

  • 1. The effects of GBR 12909, a dopamine re-uptake inhibitor, on monoaminergic neurotransmission in rat striatum, limbic forebrain, cortical hemispheres and substantia nigra.
    Nissbrandt H, Engberg G, Pileblad E.
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Jul; 344(1):16-28. PubMed ID: 1663587
    [Abstract] [Full Text] [Related]

  • 2. Synthesis and release of dopamine in rat brain: comparison between substantia nigra pars compacts, pars reticulata, and striatum.
    Nissbrandt H, Sundström E, Jonsson G, Hjorth S, Carlsson A.
    J Neurochem; 1989 Apr; 52(4):1170-82. PubMed ID: 2564423
    [Abstract] [Full Text] [Related]

  • 3. Effects of d-amphetamine on dopaminergic neurotransmission; a comparison between the substantia nigra and the striatum.
    Elverfors A, Nissbrandt H.
    Neuropharmacology; 1992 Jul; 31(7):661-70. PubMed ID: 1328918
    [Abstract] [Full Text] [Related]

  • 4. Turnover of dopamine and dopamine metabolites in rat brain: comparison between striatum and substantia nigra.
    Nissbrandt H, Carlsson A.
    J Neurochem; 1987 Sep; 49(3):959-67. PubMed ID: 3612134
    [Abstract] [Full Text] [Related]

  • 5. The influence of serotoninergic drugs on dopaminergic neurotransmission in rat substantia nigra, striatum and limbic forebrain in vivo.
    Nissbrandt H, Waters N, Hjorth S.
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Jul; 346(1):12-9. PubMed ID: 1328893
    [Abstract] [Full Text] [Related]

  • 6. Dopaminergic neurotransmission in somatodendritic and terminal areas of the rat brain: susceptibility to modulation by D1 and D2 receptors and to axotomy.
    Nissbrandt H, Hjorth S.
    J Neural Transm Gen Sect; 1992 Jul; 90(1):13-26. PubMed ID: 1361343
    [Abstract] [Full Text] [Related]

  • 7. NSD 1034: an amino acid decarboxylase inhibitor with a stimulatory action on dopamine synthesis not mediated by classical dopamine receptors.
    Nissbrandt H, Engberg G, Wikström H, Magnusson T, Carlsson A.
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Aug; 338(2):148-61. PubMed ID: 3141816
    [Abstract] [Full Text] [Related]

  • 8. [The effect of the dopamine neuronal reuptake inhibitor GBR 12909 on the dopaminergic neurotransmission parameters in the rat striatum in vivo].
    Budygin EA, Kilpatrick M, Gaĭnetdinov RR, Raevskiĭ KS, Wightman RM.
    Eksp Klin Farmakol; 1999 Aug; 62(5):3-6. PubMed ID: 10572741
    [Abstract] [Full Text] [Related]

  • 9. Neurochemical studies on central dopamine neurons--regional characterization of dopamine turnover.
    Hallman H, Jonsson G.
    Med Biol; 1984 Aug; 62(3):198-209. PubMed ID: 6492900
    [Abstract] [Full Text] [Related]

  • 10. Effect of lisuride and other ergot derivatives on monoaminergic mechanisms in rat brain.
    Kehr W.
    Eur J Pharmacol; 1977 Feb 07; 41(3):261-73. PubMed ID: 837971
    [Abstract] [Full Text] [Related]

  • 11. Reserpine-insensitive dopamine release in the substantia nigra?
    Elverfors A, Nissbrandt H.
    Brain Res; 1991 Aug 23; 557(1-2):5-12. PubMed ID: 1720998
    [Abstract] [Full Text] [Related]

  • 12. Evidence that extracellular concentrations of dopamine are regulated by noradrenergic neurons in the frontal cortex of rats.
    Pozzi L, Invernizzi R, Cervo L, Vallebuona F, Samanin R.
    J Neurochem; 1994 Jul 23; 63(1):195-200. PubMed ID: 8207428
    [Abstract] [Full Text] [Related]

  • 13. Evidence for selective inhibition of limbic forebrain dopamine synthesis by 8-OH-DPAT in the rat.
    Ahlenius S, Hillegaart V, Wijkström A.
    Naunyn Schmiedebergs Arch Pharmacol; 1989 May 23; 339(5):551-6. PubMed ID: 2570361
    [Abstract] [Full Text] [Related]

  • 14. Interaction of haloperidol and gamma-butyrolactone with (+)-amphetamine-induced changes in monoamine synthesis and metabolism in rat brain.
    Kehr W, Speckenbach W, Zimmermann R.
    J Neural Transm; 1977 May 23; 40(2):129-47. PubMed ID: 323421
    [Abstract] [Full Text] [Related]

  • 15. Evidence for dopamine release and metabolism beyond the control of nerve impulses and dopamine receptors in rat substantia nigra.
    Nissbrandt H, Pileblad E, Carlsson A.
    J Pharm Pharmacol; 1985 Dec 23; 37(12):884-9. PubMed ID: 2868096
    [Abstract] [Full Text] [Related]

  • 16. The yohimbine-induced anticonflict effect in the rat, Part II. Neurochemical findings.
    Söderpalm A, Ehrenström F, Söderpalm B.
    J Neural Transm Gen Sect; 1995 Dec 23; 100(3):191-206. PubMed ID: 8748666
    [Abstract] [Full Text] [Related]

  • 17. Effects of acute administration of SCH 23390 on dopamine and serotonin turnover in major dopaminergic areas and mesencephalic raphe nuclei--comparison with ritanserin.
    Lappalainen J, Hietala J, Koulu M, Sjöholm B, Syvälahti E.
    Prog Neuropsychopharmacol Biol Psychiatry; 1991 Dec 23; 15(6):861-72. PubMed ID: 1722342
    [Abstract] [Full Text] [Related]

  • 18. GBR 13098, a selective dopamine uptake inhibitor; behavioural, biochemical and electrophysiological studies.
    Pileblad E, Engberg G.
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Dec 23; 334(4):383-7. PubMed ID: 2950328
    [Abstract] [Full Text] [Related]

  • 19. Age effects on monoamine turnover of the rat substantia nigra.
    Venero JL, Machado A, Cano J.
    Brain Res; 1991 Aug 23; 557(1-2):109-14. PubMed ID: 1747745
    [Abstract] [Full Text] [Related]

  • 20. Comparison of the effects of dopamine D1 and D2 receptor antagonists on rat striatal, limbic and nigral dopamine synthesis and utilisation.
    Magnusson O, Mohringe B, Fowler CJ.
    J Neural Transm; 1987 Aug 23; 69(3-4):163-77. PubMed ID: 2957465
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.